Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19055047

Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic -induced hyperprolactinemia : A placebo-controlled trial

Author
SHIM, Joo-Cheol; SHIN, Jae-Goo K; KELLY, Deanna L; JUNG, Do-Un; SEO, Young-Soo; LIU, Kwang-Hyeon; SHON, Ji-Hong; CONLEY, Robert R
[1] Clinical Trial Center, Department of Psychiatry and Clinical Pharmacology, Pharmacogenomic Research Center, Busan Paik Hospital, Inje University, Korea, Republic of
[2] Dongseo Hospital and Dongrae Hospital, Masan and Busan, Korea, Republic of
[3] Maryland Psychiatric Research Center, University of Maryland, Baltimore, United States
Source

The American journal of psychiatry. 2007, Vol 164, Num 9, pp 1404-1410, 7 p ; ref : 30 ref

CODEN
AJPSAO
ISSN
0002-953X
Scientific domain
Psychology, psychopathology, psychiatry
Publisher
American Psychiatric Association, Washington, DC
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Antipsychotique atypique Aripiprazole Chimiothérapie Dopamine Essai thérapeutique contrôlé Hyperprolactinémie Neuroleptique Psychotrope Traitement adjuvant Quinolinone dérivé Agoniste partiel Antagoniste Catécholamine Endocrinopathie Hypophyse pathologie Neurotransmetteur Récepteur dopaminergique D2 Récepteur sérotoninergique 5-HT1A Récepteur sérotoninergique 5-HT2A
Keyword (en)
Atypical antipsychotic Aripiprazole Chemotherapy Dopamine Controlled therapeutic trial Hyperprolactinemia Neuroleptic Psychotropic Adjuvant treatment Partial agonist Antagonist Catecholamine Endocrinopathy Pituitary diseases Neurotransmitter D2 Dopamine receptor 5-HT1A Serotonine receptor 5-HT2A serotonin receptor
Keyword (es)
Antipsicótico atípico Aripiprazol Quimioterapia Dopamina Ensayo terapéutico controlado Hiperprolactinemia Neuroléptico Psicotropo Tratamiento adyuvante Agonista parcial Antagonista Catecolamina Endocrinopatía Hipófisis patología Neurotransmisor Receptor dopaminérgico D2 Receptor serotoninérgico 5-HT1A Receptor serotoninérgico 5-HT2A
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21A Hypothalamus. Hypophysis. Epiphysis (diseases) / 002B21A01 Non tumoral diseases. Target tissue resistance. Benign neoplasms

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E03 Psycholeptics: tranquillizer, neuroleptic…

Discipline
Endocrinopathies Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
Origin
Inist-CNRS
Database
FRANCIS ; PASCAL
INIST identifier
19055047

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web